Sample,Concentration (µg/ml),Cell viability (%),Cell viability (%),Cell viability (%),Cell viability (mean),Standard deviation (SD),,Sample,IC50 (µg/ml),IC50 (µg/ml),IC50 (µg/ml),IC50 (mean),Standard deviation (SD)
,,1,2,3,,,,,1,2,3,,
Ekstract (A),50,1.97,1.61,-2.28,0.43,1.9,,Ekstract (A),30.39,29.26,28.68,29.44,0.71
,40,31.27,27.49,26.66,28.48,2,, Fraction B,44.4,41.03,45.1,43.51,1.77
,30,54.08,51.6,51.24,52.3,1.3,,Fraction C,24.74,25.65,26.3,25.56,0.64
,20,78.42,77.94,71.21,75.86,3.3,,Lamesticumin A,15.56,15.39,16.08,15.68,0.29
,10,87.4,83.38,88.22,86.33,2.1,,Doxorubicin,0.19,0.19,0.17,0.18,0.01
 Fraction B,50,46.75,42.14,49.94,46.28,3.2,,,,,,,
,40,51.24,49.94,50.89,50.69,0.5,,,,,,,
,30,63.29,59.98,60.1,61.13,1.5,,,,,,,
,20,72.51,72.04,74.99,73.18,1.3,,,,,,,
,10,81.37,81.37,84.68,82.47,1.6,,,,,,,
Fraction C,50,-3.7,-4.41,-4.77,-4.29,0.4,,,,,,,
,40,-4.29,-1.22,-2.88,-2.8,1.3,,,,,,,
,30,11.89,29.74,30.21,23.95,8.5,,,,,,,
,20,85.27,79.48,84.21,82.99,2.5,,,,,,,
,10,88.7,88.46,91.53,89.56,1.4,,,,,,,
Lamesticumin A,25,-5.71,-5.24,-3.47,-4.81,1,,,,,,,
,20,21.58,22.88,27.73,24.06,2.6,,,,,,,
,15,62.82,61.52,67.9,64.08,2.8,,,,,,,
,10,84.32,86.69,87.4,86.14,1.3,,,,,,,
,5,102.52,94.49,99.09,98.7,3.3,,,,,,,
Doxorubicin,0.5,23.5,22.73,19.05,21.76,1.9,,,,,,,
,0.25,37.21,38.48,33.4,36.37,2.2,,,,,,,
,0.125,57.15,56.27,51.69,55.04,2.4,,,,,,,
,0.0625,87.13,93.86,77.22,86.07,6.8,,,,,,,
,0.0312,101.99,104.53,88.15,98.22,7.2,,,,,,,